著者

Takahiko Kurasawa Hayato Nagasawa Eiko Nishi Hirofumi Takei Ayumi Okuyama Tsuneo Kondo Koji Nishimura Ryota Sakai Akiko Shibata Kentaro Chino Hiroe Ogawa Tatsuya Ito Koichi Amano Hitoshi Kato

出版者

The Japanese Society of Internal Medicine

雑誌

Internal Medicine (ISSN:09182918)

巻号頁・発行日

vol.52, no.10, pp.1125-1130, 2013 (Released:2013-05-15)

参考文献数

30

被引用文献数

4 5

---

A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment. Although many of these patients respond to immunosuppressive drugs such as intravenous cyclophosphamide (IVCY), azathioprine (AZA), mizoribine, tacrolimus, cyclosporine A (CSA) and mycofenolate mofetil (MMF), some remain refractory to such therapies. Recent studies of multi-target therapies have reported effective outcomes for immunosuppression following renal transplantation and refractory LN when therapy consists of two or more immunosuppressive drugs with different mechanisms of action. We herein report a case of LN unresponsive to IVCY that was successfully treated with the addition of tacrolimus and discuss the usefulness of multi-target therapy for LN.